Dexilend 30 : Each capsule contains Dexlansoprazole INN 30 mg as enteric coated pellets.
Dexilend 60 : Each capsule contains Dexlansoprazole INN 60 mg as enteric coated pellets.
Dexilend (Dexlansoprazole) delayed-release capsule is a Proton Pump Inhibitor (PPI), that inhibits gastric
acid secretion. Dexilend (Dexlansoprazole) is the R-enantiomer of lansoprazole (A racemic mixture of the
R- and S-enantiomers). Dexilend (Dexlansoprazole) is supplied as a Dual Delayed Release (DDR)
formulation in a capsule for oral administration. Dexilend (Dexlansoprazole) capsule contains a mixture of
two types of enteric coated granules with different pH-dependent dissolution profiles.
Mechanism of Action
Dexilend (Dexlansoprazole) is a PPI that suppresses gastric acid secretion by specific inhibition of
the (H+/K+)-ATPase in the gastric parietal cell. By acting specifically on the proton pump, Dexilend
(Dexlansoprazole) blocks the final step of acid production.
Healing of Erosive Esophagitis: Dexilend (Dexlansoprazole) is indicated for healing of all grades of
Erosive Esophagitis (EE) for up to 8 weeks Maintenance of Healed Erosive Esophagitis: Dexilend
(Dexlansoprazole) is indicated to maintain healing of EE and relief of heartburn for up to 6 months
Symptomatic Non-Erosive Gastroesophageal Reflux Disease: Dexilend (Dexlansoprazole) is
indicated for the treatment of heartburn associated with symptomatic Non-Erosive Gastroesophageal
Reflux Disease (GERD) for 4 weeks.
Diarrhea, abdominal pain, nausea, upper respiratory tract Infection, vomiting & flatulence.